JP2005508352A - 新規ベンゾチアジン誘導体、その製造方法及びその使用方法 - Google Patents

新規ベンゾチアジン誘導体、その製造方法及びその使用方法 Download PDF

Info

Publication number
JP2005508352A
JP2005508352A JP2003534405A JP2003534405A JP2005508352A JP 2005508352 A JP2005508352 A JP 2005508352A JP 2003534405 A JP2003534405 A JP 2003534405A JP 2003534405 A JP2003534405 A JP 2003534405A JP 2005508352 A JP2005508352 A JP 2005508352A
Authority
JP
Japan
Prior art keywords
alkyl
cycloalkyl
sulfonyl
benzo
thiazine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003534405A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005508352A5 (cg-RX-API-DMAC10.html
Inventor
ゴウリエフ・アレックス・ハール
ラルセン・モーゲンス
ヴァルミング・トーマス
マチーセン・クラウス
ヨハンセン・チナ・ホルム
ニールセン・カリン・サンダガー
ハルツ・バルバラ
シェール−クリューガー・イェルゲン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NTG Nordic Transport Group AS
Original Assignee
Neurosearch AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch AS filed Critical Neurosearch AS
Publication of JP2005508352A publication Critical patent/JP2005508352A/ja
Publication of JP2005508352A5 publication Critical patent/JP2005508352A5/ja
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/02—1,2-Thiazines; Hydrogenated 1,2-thiazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP2003534405A 2001-10-10 2002-10-02 新規ベンゾチアジン誘導体、その製造方法及びその使用方法 Withdrawn JP2005508352A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200101498 2001-10-10
PCT/DK2002/000654 WO2003031422A1 (en) 2001-10-10 2002-10-02 Novel benzothiazine derivatives, their preparation and use

Publications (2)

Publication Number Publication Date
JP2005508352A true JP2005508352A (ja) 2005-03-31
JP2005508352A5 JP2005508352A5 (cg-RX-API-DMAC10.html) 2006-01-05

Family

ID=8160760

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003534405A Withdrawn JP2005508352A (ja) 2001-10-10 2002-10-02 新規ベンゾチアジン誘導体、その製造方法及びその使用方法

Country Status (8)

Country Link
US (1) US7199118B2 (cg-RX-API-DMAC10.html)
EP (1) EP1436270A1 (cg-RX-API-DMAC10.html)
JP (1) JP2005508352A (cg-RX-API-DMAC10.html)
CN (1) CN1275951C (cg-RX-API-DMAC10.html)
CA (1) CA2458388A1 (cg-RX-API-DMAC10.html)
MX (1) MXPA04003297A (cg-RX-API-DMAC10.html)
NZ (1) NZ531511A (cg-RX-API-DMAC10.html)
WO (1) WO2003031422A1 (cg-RX-API-DMAC10.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3547859B2 (ja) * 1995-07-14 2004-07-28 愛知機械工業株式会社 ２方向差動クラッチ
FR2856064B1 (fr) * 2003-06-13 2005-08-19 Servier Lab Nouveaux derives de benzothiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2879201B1 (fr) * 2004-12-10 2007-02-16 Servier Lab Nouveaux derives de benzothiazine et benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2933698A1 (fr) * 2008-07-09 2010-01-15 Servier Lab Nouveaux derives de benzothiadiazines cycloalkylees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2955107B1 (fr) * 2010-01-08 2012-03-02 Servier Lab Nouveaux derives thiochromanes, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO2012020848A1 (en) * 2010-08-10 2012-02-16 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof
TWI873185B (zh) 2019-09-16 2025-02-21 日商武田藥品工業股份有限公司 唑稠合之嗒-3(2h)-酮衍生物
CN111393385B (zh) * 2020-04-15 2022-01-18 华南理工大学 一种苯并噻嗪甲醛衍生物的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3113075A (en) * 1960-10-17 1963-12-03 Merck & Co Inc Heterocyclic compounds
DE1302858B (cg-RX-API-DMAC10.html) * 1962-09-21 1972-05-04
FR1552763A (cg-RX-API-DMAC10.html) * 1963-11-08 1969-01-10
FR3136M (fr) 1963-11-08 1965-02-15 Merck & Co Inc Nouveaux médicaments diurétiques.
RU2214405C2 (ru) 1998-02-18 2003-10-20 НьюроСёрч А/С Новые соединения и их применение в качестве положительных модуляторов амра-рецепторов
DE10004572A1 (de) 2000-02-02 2001-08-09 Boehringer Ingelheim Pharma Neue positive allosterische AMPA-Rezeptor Modulatoren (PAARM), Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel

Also Published As

Publication number Publication date
WO2003031422A1 (en) 2003-04-17
CN1275951C (zh) 2006-09-20
MXPA04003297A (es) 2004-07-23
EP1436270A1 (en) 2004-07-14
US20040242571A1 (en) 2004-12-02
NZ531511A (en) 2006-01-27
CA2458388A1 (en) 2003-04-17
CN1564817A (zh) 2005-01-12
US7199118B2 (en) 2007-04-03

Similar Documents

Publication Publication Date Title
TWI905095B (zh) 用於治療腦機能障礙的氮呯-吲哚及其他雜環
IL174942A (en) Derivatives of n-[phenyl(piperidine-2-yl)methyl]arylamides, pharmaceutical compositions comprising them and their use in the preparation of medicaments
JP2025138744A (ja) てんかんを治療する方法を使用しててんかんを治療する方法
CN1330655A (zh) 稠合的1,2,4－噻二嗪衍生物、其制备方法和用途
JP2006507329A (ja) 新規アリールウレイド安息香酸誘導体及びその使用
US10729684B2 (en) Alkynyl dihydroquinoline sulfonamide compounds
JP2015124178A (ja) 環状アミン誘導体及びその医薬用途
US20200009129A1 (en) Alkyl dihydroquinoline sulfonamide compounds
US8563742B2 (en) Substituted aminothiazole derivatives, pharmaceutical compositions, and methods of use
JP2017132781A (ja) ベンゾチアゾロン化合物
JP5628937B2 (ja) ５−ｈｔ６受容体リガンドとしてのスルホン化合物
US7145037B2 (en) Adamantane derivatives with neuroprotective, antidepressant and anti-ischaemic activities, and process for preparing them
US7049330B2 (en) Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents
US7199118B2 (en) Benzothiazine derivatives, their preparation and use
JP3164372B2 (ja) 融合インドール及びキノキサリン誘導体、その製造および使用
KR20220158290A (ko) 신경퇴행성 및 미토콘드리아 질환의 치료를 위한 조성물 및 이를 사용하는 방법
JP2003520851A (ja) 神経栄養活性を有するイサチン誘導体
GB2073747A (en) Triazolopyridinone compounds process for the preparation thereof and pharmaceutical preparations containing them
KR100636515B1 (ko) 신규 형태의 축합 피리다지논 화합물
AU2002333216A1 (en) Novel benzothiazine derivatives, their preparation and use
JP5858298B2 (ja) ヘキセノン化合物及びその医学的使用
CN1323294A (zh) 环状酯或酰胺衍生物
HK1201837A1 (en) Deuterated thiazolidinone analogues as agonists for follicle stimulating hormone receptor
FR2616149A1 (fr) Nouveau derive de l'acide benzo (b) thiophene - 7 carboxylique, son procede de preparation et les compositions pharmaceutiques qui le contiennent
JPH05201976A (ja) 新規イサチンオキシム誘導体、その製造方法および使用方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050915

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050915

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20070105